Orion Star & Associates Inc. – FDA Warning Letter
The FDA issued a Warning Letter to the operators of i-want-rx.com, refill-online.com, ultra-rx.com, trust-pharm.com, trust-european-pharmacy.com, pill-planet.com, and pharmacy-usa.biz for offering violative drug products for sale. The products, including "Acomplia (Brand/Generic)," "Rimonabant," "Viagra (Brand)," "Cialis (Brand)," "Prozac (Generic)," and "Levitra (Brand)," are considered drugs under section 201(g) of the Act.
The violations include marketing unapproved new drugs, specifically "Acomplia" and "Rimonabant," which were rejected for FDA approval due to safety concerns like neurological and psychiatric side effects. Selling these without FDA-approved applications violates sections 301(d) and 505(a) of the Act.
Additionally, many products, such as "Viagra," "Cialis," "Prozac," and "Levitra," are sold without requiring a prescription from a licensed practitioner, rendering them misbranded under section 503(b)(1) and violating sections 301(a), 301(b), and 301(k). The websites also falsely claim FDA approval for their products, making them misbranded under section 502(a) due to false and misleading labeling
- Company
- Orion Star & Associates Inc.
- Product type
- Drugs
ID · 48b21aab-97cc-4a22-881f-e234aec67236
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.